North America Glucose Monitoring Devices Market Size & Outlook, 2025-2033
North America Glucose Monitoring Devices Market Insights
- As highlighted in Reed Intelligence analysis, the North America Glucose Monitoring Devices Market, valued at USD 6106.32 Million in 2024, is estimated to achieve USD 14229.52 Million by 2033.
- The market is estimated to grow at a CAGR of 9.8% spanning 2026 to 2033.
- By market size, Self-monitoring Devices led the By Product category in 2024.
- The By Product segment led by Self-monitoring Devices is estimated to post the fastest growth, sustaining its position as the most lucrative during the forecast timeframe.
![North America Glucose Monitoring Devices Market Size, Share & Growth Report By [2033]](https://reedintelligence.com/uploads/charts/glucose-monitoring-devices-market-north-america--36145.png)
Source: RI Analysis Company Publications, Primary Interviews.
Other Key Findings
- The global Glucose Monitoring Devices Market size saw North America holding a share of 33.83% in 2024.
- United States is forecasted to account for the leading share of the global market by 2033.
- In North America, United States is forecasted to be the fastest-expanding market, projected to reach USD 10114.03 Million by 2033.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2024 |
| Study Period | 2021-2033 |
| Historical Period | 2021-2023 |
| Forecast Period | 2025-2033 |
| Market Size In 2024 | USD 6106.32 Million |
| Market Size In 2033 | USD 14229.52 Million |
| Largest segment | Self-monitoring Devices |
| Units | Revenue in USD Million |
| CAGR | 9.8% (2025-2033) |
| Segmnetation Covered | |
| North America |
|
| By Product |
|
| By End-User |
|
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
North America Glucose Monitoring Devices Market Country 2025-2033 (USD Million)
| North America | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | XX.x | XX.x | XX.x | 4310.45 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Canada | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
North America Glucose Monitoring Devices Market By Product 2025-2033 (USD Million)
| By Product | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Self-monitoring Devices | XX.x | XX.x | XX.x | 3886.06 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Continuous Blood Glucose Monitoring Devices | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
North America Glucose Monitoring Devices Market By End-User 2025-2033 (USD Million)
| By End-User | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospitals | XX.x | XX.x | XX.x | 3329.78 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Home Care | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Diagnostic Centers | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
